Biolife Science's Acquisition

Biolife Science was acquired by Imugene on October 23, 2013.

Biolife is a biopharmaceutical company focussed on immunotherapy in oncology, with a lead product targeting gastric cancer and breast cancer, in addition to other indications including melanoma and br…

Articles about Biolife Science's Acquisition: